Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 189
Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
Francesco Menegale, Mattia Manica, Agnese Zardini, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2310650-e2310650
Open Access | Times Cited: 178
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 82
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 779-811
Open Access | Times Cited: 10
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Wilhelmine Meeraus, Mark Joy, Mario Ouwens, et al.
Journal of Infection (2024) Vol. 88, Iss. 4, pp. 106129-106129
Open Access | Times Cited: 7
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 6
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE
Xuan Wang, Ankit Pahwa, Mary T. Bausch-Jurken, et al.
Advances in Therapy (2025)
Open Access
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study
Ruby S. M. Tsang, Mark Joy, Rachel Byford, et al.
Eurosurveillance (2023) Vol. 28, Iss. 3
Open Access | Times Cited: 12
Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
Leire Fernández-Ciriza, Álvaro González, José Luís del Pozo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization
Marije K. Verheul, Kim H. Nijhof, Mary‐lène de Zeeuw‐Brouwer, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1196-1196
Open Access | Times Cited: 7
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
Charlotte Lanièce Delaunay, Clara Mazagatos, Iván Martínez‐Baz, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2419258-e2419258
Open Access | Times Cited: 2
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
Catharina E van Ewijk, Marjolein N. Kooijman, Ewout Fanoy, et al.
Eurosurveillance (2022) Vol. 27, Iss. 45
Open Access | Times Cited: 11
Diverse roles of Primary Health Care in COVID-19 vaccination across 28 European countries – Insights from the Eurodata study
Marina Guisado‐Clavero, Raquel Gómez Bravo, Ileana Gefaell Larrondo, et al.
European Journal of General Practice (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain
Clara Mazagatos, Concepción Delgado‐Sanz, Susana Monge, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 6, pp. 1014-1025
Open Access | Times Cited: 8
Vaccination policy and mortality from COVID-19 in the European Union
Eleonora Agostini, Francesco Bloise, Massimiliano Tancioni
Econometrics Journal (2024) Vol. 27, Iss. 2, pp. 299-322
Closed Access | Times Cited: 1
Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients
Marijana Mikačić, Marko Kumrić, Martina Baricevic, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3699-3699
Open Access | Times Cited: 7
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
Marjan Meurisse, Lucy Catteau, Joris Adriaan Frank van Loenhout, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 378-378
Open Access | Times Cited: 3
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The Potential Bias Introduced into COVID-19 Vaccine Effectiveness Studies at Primary Care Level Due to the Availability of SARS-CoV-2 Tests in the General Population
Charlotte Lanièce Delaunay, Alexandra Nunes, Susana Monge, et al.
(2024)
Closed Access
Data Resource Profile: Results Analysis Base of Navarre (BARDENA)
Javier Gorricho, Leire Leache, Ibai Tamayo, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 6, pp. e301-e307
Open Access | Times Cited: 1
Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
Matthieu Buscot, Marion Crémoni, Daisy Graça, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Page 1

Scroll to top